FGF9 and hepatocellular carcinoma: In a three‐dimensional assay for bulky invasion, HepG2, Hep3B and HCC‐1.2 cells formed considerably larger spheroids when treated with FGF9 than in controls, probably as a consequence of elevated cell proliferation.